Nummular keratitis: A rare manifestation of brimonidine allergy

Nummular keratitis: A rare manifestation of brimonidine allergy

A 32-year-old male, with juvenile open-angle glaucoma on chronic antiglaucoma therapy and recently introduced brimonidine eye drops to the treatment regimen, developed bilateral follicular conjunctivitis with subepithelial infiltrates (SEIs) initially resembling common infectious keratoconjunctiviti...

Full description

Bibliographic Details
Main Authors:	Maitha Al Asmi, Aisha Al Busaidi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-01-01
Series:	Oman Journal of Ophthalmology
Subjects:	allergy brimonidine corneal subepithelial infiltrates keratoconjunctivitis
Online Access:	http://www.ojoonline.org/article.asp?issn=0974-620X;year=2024;volume=17;issue=1;spage=113;epage=116;aulast=Al

Similar Items

A 8-year retrospective clinical analysis of 272 patients of epidemic Keratoconjunctivitis in Beijing, China
by: Wenbo Hou, et al.
Published: (2019-12-01)

Effect of brimonidine tartrate on basophil activation in glaucoma patients
by: Eldar Rosenfeld, et al.
Published: (2020-03-01)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
by: Okumus Seydi, et al.
Published: (2012-08-01)

Evaluating anterior corneal surface using Placido ring mires for irregular astigmatism in refractory corneal subepithelial infiltrates after adenoviral conjunctivitis
by: Noriko Toyokawa, et al.
Published: (2024-11-01)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
by: Betül N. Bayraktutar, et al.
Published: (2016-03-01)

Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis
by: Rahul Bhargava, et al.
Published: (2019-01-01)

Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01)

In Vivo Confocal Microscopic Findings of Subepithelial Infiltrates Associated with Epidemic Keratoconjunctivitis
by: Sibel Kocabeyoğlu, et al.
Published: (2015-05-01)

FEATURES OF 0.05% CYCLOSPORINE (RESTASIS) APPLICATION IN TREATMENT OF RECURRENT INFILTRATIVE ADENOVIRAL KERATITIS
by: D. Y. Maychuk, et al.
Published: (2015-10-01)

Efficacy and safety of 0.1 % brimonidine as a starting monotherapy and when added to combination therapy of glaucoma
by: E. D. Semenov, et al.
Published: (2024-12-01)

Neuroprotective properties of Brimonidine
by: Т. N. Mikhailova
Published: (2019-11-01)

Brimonidine-associated uveitis – a descriptive case series
by: Susanne Hopf, et al.
Published: (2020-12-01)

<italic>In Vivo</italic> Confocal Microscopy Analysis of the Corneal Layers in Adenoviral Epidemic Keratoconjunctivitis
by: Sevgi Subaşı, et al.
Published: (2018-12-01)

Topography-Guided Transepithelial Photorefractive Keratectomy for the Treatment of Persistent and Visually-Significant Adenoviral Corneal Infiltrates
by: Spadea L, et al.
Published: (2023-04-01)

Comparative Evaluation of the Efficacy and Safety of Brimonidine Generics in Glaucoma Therapy
by: A. A. Antonov, et al.
Published: (2023-12-01)

Brimonidine as a possible treatment for myopia
by: Zixuan Peng, et al.
Published: (2024-04-01)

Comparison between the Efficacy and Tolerability of Polyvinylpyrrolidone-Iodine Eye Drops 0.6% and 1% in Adenoviral Keratoconjunctivitis: A Randomized Clinical Trial
by: Ali Makateb, et al.
Published: (2024-08-01)

Intravitreal brimonidine inhibits form-deprivation myopia in guinea pigs
by: Yifang Yang, et al.
Published: (2021-07-01)

Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial
by: Anubha Bhatti, et al.
Published: (2018-01-01)

Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
by: Inoue K, et al.
Published: (2024-02-01)

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
by: Reza Moosavi, et al.
Published: (2018-10-01)

Efficacy and safety of various brimonidine formulations in the treatment of glaucoma and ocular hypertension
by: A. V. Sidorova, et al.
Published: (2021-07-01)

Topical brimonidine for pyogenic granuloma after paronychia surgery
by: Yusha Chen, MM, et al.
Published: (2021-01-01)

Pharmacodynamic approach for proving equivalence of two ophtalmic solutions containing Brimonidine Tartarate 0.2% in healthy volunteers
by: Hristova-Valcheva Ruska, et al.
Published: (2018-01-01)

Sequelae of microsporidial keratoconjunctivitis and its management
by: Amrita Mohanty, et al.
Published: (2021-01-01)

Brimonidine Eye Drops within the Reach of Children: A Possible Foe
by: Daniela Trotta, et al.
Published: (2024-03-01)

Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy
by: Oya Tekeli, et al.
Published: (2022-08-01)

Comparison of allergy prevalence using brinzolamide 1.0% / brimonidine 0.2% fixed combination with and without β-blocker in glaucoma patients: a retrospective cohort study
by: In Ki Park, et al.
Published: (2024-07-01)

Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report
by: Yakun Li, et al.
Published: (2023-10-01)

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery
by: Haonan Xu, et al.
Published: (2023-01-01)

Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
by: Thomas Ravi, et al.
Published: (2003-01-01)

Ocular allergy
by: Khathutshelo P. Mashige
Published: (2017-10-01)

Comparative Analysis of Pupil Diameters in Light and Dark Conditions After Instillation of 0.15% Brimonidine Drops in Eyes With and Without Pseudoexfoliation Syndrome
by: Sercan Cate, et al.
Published: (2020-12-01)

Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu, Japan
by: Uemura T, et al.
Published: (2018-03-01)

About the pathways to deliver brimonidine to the Muller’s muscle
by: Soha Ghanian, MD, et al.
Published: (2023-03-01)

Bilateral disciform keratitis of presumed adenoviral etiology
by: Rana Altan-Yaycioglu, et al.
Published: (2018-01-01)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
by: Ruiz Simonato Alonso, et al.
Published: (2020-03-01)

Unilateral floppy eyelid syndrome with ipsilateral intolerance to brimonidine
by: Leidiane Adriano Pereira, et al.

Comparison of brimonidine-timolol and dorzolamide-timolol in the management of intraocular pressure increase after phacoemulsiﬁcation
by: Adem Turk, et al.
Published: (2015-10-01)

Study of Intraocular Pressure following Neodynium Yttrium Aluminium Garnet Laser Capsulotomy with the Use of Brimonidine: A Descriptive Cross-sectional Study
by: Laxmi Devi Manandhar, et al.
Published: (2021-01-01)